- Report
- July 2024
- 153 Pages
Global
From €3186EUR$3,613USD£2,774GBP
€3748EUR$4,250USD£3,263GBP
- Report
- December 2023
- 140 Pages
Global
From €3924EUR$4,450USD£3,417GBP
- Report
- August 2024
- 200 Pages
Global
From €3412EUR$3,869USD£2,971GBP
- Report
- August 2024
- 200 Pages
Global
From €3412EUR$3,869USD£2,971GBP
- Report
- June 2024
- 140 Pages
Africa, Middle East
From €3412EUR$3,869USD£2,971GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3412EUR$3,869USD£2,971GBP
- Report
- June 2024
- 140 Pages
Europe
From €3412EUR$3,869USD£2,971GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3412EUR$3,869USD£2,971GBP
- Report
- April 2024
- 140 Pages
Global
From €4364EUR$4,949USD£3,800GBP
- Report
- November 2023
- 160 Pages
South Korea
From €3174EUR$3,599USD£2,763GBP
- Report
- May 2023
- 140 Pages
Global
From €4364EUR$4,949USD£3,800GBP
- Report
- May 2023
- 95 Pages
Global
From €3500EUR$4,252USD£3,154GBP
- Report
- September 2024
- 173 Pages
Global
From €3527EUR$4,000USD£3,071GBP
- Report
- July 2024
- 70 Pages
Global
From €3527EUR$4,000USD£3,071GBP
- Report
- July 2024
- 68 Pages
Global
From €2205EUR$2,500USD£1,920GBP
- Report
- July 2024
- 185 Pages
Global
From €3527EUR$4,000USD£3,071GBP
- Report
- May 2024
- 128 Pages
Global
From €3527EUR$4,000USD£3,071GBP
- Report
- September 2023
- 179 Pages
Global
From €3527EUR$4,000USD£3,071GBP
- Report
- May 2024
- 100 Pages
Africa
From €882EUR$1,000USD£768GBP
€1764EUR$2,000USD£1,536GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €661EUR$750USD£576GBP
€1323EUR$1,500USD£1,152GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more